Yingzi Yang
Has grant
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Cellular and molecular control of periodontal tissue regeneration
Open Date: 2025-04-16
Close Date: 2030-03-31
Grant: Open
Defining Novel Cellular Circuitry and Communication in Fibrous Dysplasia
Open Date: 2023-08-01
Close Date: 2027-07-31
Grant: Close
Piezo1-Mediated Mechanotransduction as Key Regulator of Bone Health in Adult Mice
Open Date: 2021-09-15
Close Date: 2026-09-14
Grant: Close
2018 Cartilage Biology and Pathology Gordon Research Conferences
Open Date: 2019-02-01
Close Date: 2020-01-31
Grant: Close
Cellular and molecular mechanism of Hippo signaling in suppressing liver tumor formation
Open Date: 2018-08-30
Close Date: 2024-07-31
Articles (5)
Year:
2026
Year:
2026
Cancer-associated cachexia is a severe metabolic syndrome marked by dramatic loss of adipose and muscle mass. Although preclinical models have advanced our understanding of cachexia, there are still no approved therapies due to the limited insights into the mechanisms underlying tissue wasting. Here, we utilise a YAP-driven model of liver cancer in zebrafish, which rapidly develops cachexia, to uncover an evolutionarily conserved role for bile acid disruption in the onset of cachexia. Spatial transcriptomic analysis revealed that YAP induces a bi-lineage cholangiocarcinoma phenotype, which was associated with bile acid dysregulation. Mechanistically, we establish that both bile acid synthesis (via CYP7A1) and signalling through the bile acid receptor TGR5 are essential for cachexia induction. Notably, we find that the promotion of bile acid excretion with odevixibat ameliorates cachexia. Together, our findings reveal an evolutionarily conserved mechanism by which YAP promotes cachexia and suggest a potential therapeutic strategy to treat the syndrome.
Year:
2026
Stem cells reside in niches that determine how they respond to injury to expand in number, migrate to the injury site, and differentiate into cells to regenerate lost tissue. Suture stem cells (SuSCs) are important for homeostasis and regeneration of cranial bone and can be used as a model to understand stem cell regulation for bone regeneration at a distance. Using a mouse cranial bone injury model, we identified the chemokine Cxcl12 and the Hedgehog family ligands Shh and Ihh as injury-induced niche factors that coordinately promoted the proliferation, directional migration, and osteoblastic differentiation of the Gli1 + subset of SuSCs from the sagittal suture. Cxcl12 was constitutively produced in the SuSC niche, induced at the injury site, and activated its cognate receptor Cxcr4 on Gli1 + SuSCs to stimulate Gli1 + SuSC proliferation and migration to the injury site. Cxcl12-Cxcr4 signaling also induced the production of Shh and Ihh, which promoted Gli1 + SuSC proliferation and osteoblastic differentiation. Furthermore, expressing loss- or gain-of-function mutant forms of the G protein Gα s , which cause inherited diseases characterized by cranial bone defects, led to aberrant Cxcl12, Shh, and Ihh signaling during regeneration and resulted in cranial bone phenotypes similar to those in human patients. Our results indicate that the injury-induced niche factors Cxcl12, Shh, and Ihh orchestrate SuSC activation and migration to promote injury repair and suggest that disrupting this system impairs regeneration and contributes to human disease.
Year:
2025
Hepatocyte organoids (HOs) generated in vitro are powerful tools for liver regeneration. However, previously reported HOs have mostly been fetal in nature with low expression levels of metabolic genes characteristic of adult liver functions, hampering their application in studies of metabolic regulation and therapeutic testing for liver disorders. Here, we report development of novel culture conditions that combine optimized levels of triiodothyronine (T3) with the removal of growth factors to enable successful generation of mature hepatocyte organoids (MHOs) of both mouse and human origin with metabolic functions characteristic of adult livers. We show that the MHOs can be used to study various metabolic functions including bile and urea production, zonal metabolic gene expression, and metabolic alterations in both alcoholic liver disease and non-alcoholic fatty liver disease, as well as hepatocyte proliferation, injury and cell fate changes. Notably, MHOs derived from human fetal hepatocytes also show improved hepatitis B virus infection. Therefore, these MHOs provide a powerful in vitro model for studies of human liver physiology and diseases. The human MHOs are potentially also a robust research tool for therapeutic development.
Year:
2024
Collaborators (7)
Andrew Cox
Group Leader
Peter MacCallum Cancer Institute
Fumiko Usami
Okayama University
Toshihiko Fujimori
Professor
The Graduate University for Advanced Studies, SOKENDAI
Kimberley Evason
Associate Professor
University of Utah
Kristin Brown
Senior Research Fellow
University of Melbourne
Masaki Arata
特任助教/Research Assistant Professor
基礎生物学研究所/National Institute for Basic Biology
Takehito Ouchi
Tokyo Dental College
Make your next move.
Prepare your application
Review drafts before you send them.